COVID-19 vaccination in Morocco

COVID-19 vaccination in Morocco
Date28 January 2021 – present
LocationMorocco, Vaccination clinics
CauseCOVID-19 pandemic
TargetImmunization against COVID-19
Organised byMinistry of Health (Morocco)
Participants45,249,522 total doses administered[1][a]
Outcome62.43% of the Moroccan population has received at least one dose of a vaccine
56.84% has been fully vaccinated

The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

The Ministry of Health has approved the following COVID-19 vaccines: Oxford–AstraZeneca, Sputnik V, and Sinopharm BIBP.

On 28 January 2021, Morocco launched a coronavirus vaccination campaign, a week after receiving its first shipment of the Oxford–AstraZeneca and Sinopharm BIBP vaccines.[2]

Background

The government has secured 66 million doses from different manufacturers such as AstraZeneca and Sinopharm.[2]

Local production

In July 2021, it was announced that the Moroccan pharmaceutical firm Sothema would start to locally produce 5 million doses of the Sinopharm BIBP vaccine per month.[3][4]

Timeline

January 2021

In January, Morocco approved the following vaccines: Sputnik V, Sinopharm BIBP, and Oxford–AstraZeneca.[5]

On 22 January, the first batch of the Oxford–AstraZeneca vaccine, consisting of 2,000,000 doses, arrived in Morocco.[6]

On 27 January, the first batch of the Sinopharm BIBP vaccine, consisting of 500,000 doses, arrived in Morocco.[7]

February 2021

On 11 & 16 February, the second batches of the Oxford–AstraZeneca and Sinopharm BIBP vaccines, consisting of 4,500,000 doses, arrived in Morocco.[8][9]

By the end of the month, 3.6 million vaccine doses had been administered.

March 2021

By the end of March, 7.6 million vaccine doses had been administered while 22% of the target population had been fully vaccinated.

April 2021

On 8 April, a batch of the Oxford–AstraZeneca vaccine, approximately 307,200 doses, arrived in Morocco from COVAX facility.[10]

On 26 & 30 April, two batches of the Sinopharm BIBP vaccine, consisting of 1,000,000 doses, arrived in Morocco.[11]

By the end of the month, 9 million vaccine doses had been administered while 28% of the target population had been fully vaccinated.

May 2021

On 15-16 May, a batch of the Oxford–AstraZeneca vaccine, approximately 650,000 doses, arrived in Morocco.[11]

On 19 & 23 May, two batches of the Sinopharm BIBP vaccine, consisting of 4,000,000 doses, arrived in Morocco.[11]

By the end of the month, 14 million vaccine doses had been administered while 35% of the target population had been fully vaccinated.

June 2021

In the first five months of the vaccination campaign, almost 10 million people received their first inoculation and 9.1 million were fully vaccinated.[12]

By the end of the month, 19 million vaccine doses had been administered while 59% of the target population had been fully vaccinated.

July 2021

On 13 & 17 July, two batches of 2,000,000 doses of the Sinopharm BIBP vaccine arrived in Morocco.[13][14]

By the end of the month, 24 million vaccine doses had been administered while 68% of the target population had been fully vaccinated.

August 2021

By the end of August, 33 million vaccine doses had been administered while 88% of the target population had been fully vaccinated.

September 2021

By the end of September, 41 million vaccine doses had been administered and 19 million persons were fully vaccinated. The entire targeted population had been fully vaccinated by mid-September.

October 2021

By the end of October, 46 million vaccine doses had been administered and 22 million persons were fully vaccinated, exceeding the targeted population.

November 2021

By the end of November, 47 million vaccine doses had been administered and 23 million persons were fully vaccinated, exceeding the targeted population.

December 2021

By the end of December, 48 million vaccine doses had been administered and 23 million persons were fully vaccinated, exceeding the targeted population.

January 2022

By the end of January, 48 million vaccine doses had been administered and 23 million persons were fully vaccinated, exceeding the targeted population.

Vaccines

Morocco has received 7 million doses of the Oxford–AstraZeneca COVID-19 vaccine and 16.5 million doses of the Sinopharm BIBP vaccine.

Vaccines in order
VaccineApprovalDeploymentDoses ordered
Sinopharm BIBPGreen check.svg YesGreen check.svg 28 January 202145 million
Oxford–AstraZenecaGreen check.svg 6 January 2021Green check.svg 28 January 202120 million
Sputnik VGreen check.svg 10 March 2021Dark Red x.svg No
Vaccines in trial stage
VaccineType (technology)Phase IPhase IIPhase III
Sinopharm WIBPInactivatedGreen check.svg CompletedGreen check.svg CompletedGreen check.svg Completed

Progress

Cumulative vaccinations in Morocco[15]

Priority groups

The vaccination campaign primarily targets health workers, security forces and people over 75, according to Moroccan authorities.[2]

Notes

  1. ^ At least 23,333,590 of these have only been administered with the first dose, while 21,116,355 have been fully vaccinated and 799,577 have received a booster shot.

References

  1. ^ "Vaccine Statistics: As of October 21, 2021". covidvax.live. Retrieved 22 October 2021.
  2. ^ a b c AfricaNews (28 January 2021). "Morocco kicks off coronavirus vaccination drive". Africanews. Retrieved 7 March 2021.
  3. ^ "Morocco's Sothema to produce China's Sinopharm vaccine". Zawya. 5 July 2021. Retrieved 22 July 2021.
  4. ^ "Morocco seeks self-sufficiency, helping Africa through vaccine production". The Arab Weekly. 16 July 2021. Retrieved 23 July 2021.
  5. ^ "Morocco – COVID19 Vaccine Tracker". covid19.trackvaccines. Archived from the original on 19 November 2020. Retrieved 22 July 2021.
  6. ^ "Morocco gets 2 million AstraZeneca vaccine doses, first big shipment to Africa". Reuters. 22 January 2021. Retrieved 22 July 2021.
  7. ^ "Morocco receives 1st batch of Chinese Sinopharm COVID-19 vaccines". Xinhuanet. 28 January 2021. Retrieved 22 July 2021.
  8. ^ "Morocco receives 4 million doses of AstraZeneca vaccine from India". Reuters. 11 February 2021. Retrieved 22 July 2021.
  9. ^ "Morocco receives second batch of 500,000 Sinopharm doses". Reuters. 16 February 2021. Retrieved 22 July 2021.
  10. ^ "COVID-19: Morocco Receives First Batch of COVAX Vaccines". Morocco World News. 9 April 2021. Retrieved 22 July 2021.
  11. ^ a b c "Morocco Receives Additional 2 Million COVID-19 Vaccines from Beijing". Morocco World News. 24 May 2021. Retrieved 22 July 2021.
  12. ^ "Covid: 776 nouveaux cas, 4 décès". L'Economiste (in French). 30 June 2021. Retrieved 9 July 2021.
  13. ^ "Morocco receives 2 million doses of Chinese vaccine Sinopharm". Morocco Latest News. 13 July 2021. Retrieved 22 July 2021.
  14. ^ "Sinopharm Delivers Two Million Doses of COVID-19 Vaccines to Morocco". Morocco World News. 17 July 2021. Retrieved 22 July 2021.
  15. ^ "Vaccine Statistics: As of 16 August 2021". covidvax.live. Archived from the original on 18 February 2021. Retrieved 22 July 2021.

Media files used on this page

Green check.svg
Green check icon
Dark Red x.svg
Dark Red "X"/Cross logic icon.
SARS-CoV-2 (Wikimedia colors).svg
Author/Creator: Geraki, Licence: CC BY-SA 4.0
SARS-CoV-2 logo in Wikimedia colors
SARS-CoV-2 (CDC-23312).png
This illustration, created at the Centers for Disease Control and Prevention (CDC), reveals ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV). Note the spikes that adorn the outer surface of the virus, which impart the look of a corona surrounding the virion, when viewed electron microscopically. This virus was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China.